This test is most useful if any of these apply to you.
If a heart CT finds plaque in the left circumflex artery, the next question is whether it restricts blood flow to the heart muscle. FFRCT helps answer that question by estimating pressure along the artery. The distal result comes from its far end, where the effects of upstream narrowings, diffuse plaque, and vessel shape have accumulated.
FFRCT is an established tool for evaluating intermediate coronary narrowings, especially when you have stable chest symptoms. The evidence for using an isolated far-end circumflex value to make treatment decisions is less developed. It belongs with the CT images and the pressure readings around any narrowing.
FFRCT stands for fractional flow reserve derived from coronary CT angiography. It estimates the ratio of pressure inside a coronary artery to pressure in the aorta during simulated maximum blood flow. The aorta carries blood out of the heart. Lower ratios represent greater estimated pressure loss.
Software builds a three-dimensional model of the coronary arteries from the CT images. The standard HeartFlow FFRCT analysis uses physics-based blood-flow modeling to estimate the pressure along those vessels. This is an imaging-derived result; it doesn't measure a substance in blood or directly measure the volume of blood reaching the muscle.
The left circumflex artery branches from the left main coronary artery and curves around the side and back of the heart. Its distal reading includes pressure losses along the modeled path. A focal narrowing can produce a sharp drop, while diffuse disease or vessel geometry can produce a gradual decline. The distal number alone cannot locate the source of that loss.
A lesion-specific reading is taken a short distance downstream from a particular narrowing. Comparing it with the reading before that narrowing helps assess its contribution. This distinction matters because the far-end value can be low even when no single narrowing restricts flow enough to warrant a procedure.
The circumflex generally has higher FFRCT readings than the left anterior descending artery, which runs down the front of the heart. That pattern appeared in the ADVANCE registry of more than 5,000 people with suspected coronary disease. Those clinical measurements weren't a reference range for a fixed point at the end of the circumflex. Vessel length, branching pattern, and the amount of muscle supplied all affect the pressure profile.
Lower FFRCT values are associated with more heart attacks and cardiovascular deaths in people evaluated for coronary disease. Most outcome studies combine information from several arteries and use either readings below a narrowing or the lowest distal value. Their risk estimates don't apply directly to your distal circumflex number in isolation.
A nationwide English study followed 7,836 people for about three years. Markedly reduced readings below a narrowing were associated with about three times the heart attack risk after accounting for clinical risk factors and the degree of narrowing on CT. The lowest category also had about three times the risk of cardiovascular death. Among people whose lesion-specific readings were reassuring, about 1.5% had a heart attack or cardiovascular death over three years. Distal readings also predicted events, although lesion-specific readings provided somewhat better information for predicting heart attacks.
A meta-analysis of 22 studies found that abnormal CT-derived pressure ratios were associated with roughly four times the risk of major cardiovascular events and roughly three times the risk of death or heart attack. The studies used different software, measurement locations, and outcome definitions. Some combined outcomes included procedures that the test result itself could influence, and evidence of publication bias made the size of the association less certain.
These studies support FFRCT as one part of risk assessment. They don't establish that raising a distal circumflex value prevents a heart attack, or that a low value by itself identifies an artery that needs a stent. Plaque can remain clinically relevant even when it doesn't restrict flow.
A study of male marathon runners illustrates the problem. Of 98 enrolled runners, 59 without coronary narrowing were evaluated with an investigational on-site CT-FFR prototype. About 37% had at least one distal reading classified as abnormal, including five with a low distal circumflex reading. This was different software from standard HeartFlow FFRCT, and there was no invasive pressure-wire comparison. The finding supports caution about terminal readings; it doesn't establish this test's false-positive rate.
In a separate study using HeartFlow in arteries without apparent coronary disease, longer vessels and wider branching angles were associated with lower distal readings. Diffuse plaque can also cause a gradual pressure decline without forming one tight blockage. These are possible explanations for a low value, so a scan without a focal narrowing requires interpretation of the full vessel and image quality before the number is attributed to disease.
Measurement location changes interpretation. In one study, about 44% of people classified as abnormal using the lowest vessel value were reclassified as negative when the reading just downstream from a narrowing was used instead. That was a change in classification, not proof that every reclassified person had healthy arteries.
A study with invasive pressure-wire measurements as the reference found that readings taken 1 to 2 cm beyond a narrowing correctly classified more vessels without flow-limiting disease than far-end readings did. This study included several coronary arteries and did not separately validate the distal circumflex result.
A small study of independent analyses of the same CT images reported about 3% relative variability. That result doesn't establish how much change between separate scans is meaningful. A new scan also introduces differences in image quality, vessel widening, and the exact point being compared. Women had higher FFRCT values than men at comparable degrees of narrowing in the ADVANCE registry, another reason to interpret the number in context.
In an observational study of 71 adults scanned about five years apart, distal readings improved in about 28% of vessels, remained stable in about 45%, and worsened in about 27%. Improvement was associated with less high-risk plaque and a wider vessel opening. Higher total cholesterol and increasing narrowing were associated with worsening readings.
The study combined several coronary arteries and used study-specific definitions of change. It supports investigating distal FFRCT as a way to follow coronary disease, but it doesn't establish a circumflex-specific treatment target or show that scheduled repeat scans improve health outcomes.
Evidence-backed interventions that affect your FFRCT - LCX (Distal) level
FFRCT - LCX (Distal) is best interpreted alongside these tests.